Information for the public
Tezepelumab (Tezspire) is available on the NHS as a possible additional maintenance treatment for severe asthma. It is available for people 12 years and over when treatment with high-dose inhaled corticosteroids plus another maintenance treatment has not worked well enough, if:
- there have been 3 or more episodes of worse asthma in the previous year, or
- the person is taking maintenance oral corticosteroids.
Tezepelumab can be used for longer than 12 months only if it is working well.
If you are not eligible for tezepelumab but are already having it, you should be able to continue until you and your doctor decide when best to stop.
Is this treatment right for me?
Your healthcare professionals should give you clear information, talk with you about your options and listen carefully to your views and concerns. Your family can be involved too, if you wish. See our webpage on making decisions about your care.
Questions to think about
- How well does it work compared with other treatments?
- What are the risks or side effects? How likely are they?
- How will the treatment affect my day-to-day life?
- What happens if the treatment does not work?
- What happens if I do not want to have treatment? Are there other treatments available?
Information and support
The NHS webpage on asthma may be a good place to find out more.
Asthma and Lung UK (0300 222 5800) can give you advice and support.
You can also get support from your local Healthwatch.
NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.
ISBN: 978-1-4731-5162-8
This page was last updated: